AMBROXOL AS PHARMACOLOGICAL CHAPERONE TARGETING GBA1 AS A DISEASE MODIFYING TREATMENT FOR PARKINSON’S DISEASE DEMENTIA: A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

Saved in:
Bibliographic Details
Published inAlzheimer's & dementia Vol. 14; no. 7; p. P296
Main Authors Pasternak, Stephen H., Silveira, Carolina, Li, Zhonghan, Bartha, Robert, Borrie, Michael, Wells, Jennie, MacDonald, Penny, Zou, Guangyoug, Jenkins, Mary, Finger, Elizabeth, Jog, Mandar, Rupar, Tony, Tirona, Rommel
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.07.2018
Online AccessGet full text

Cover

More Information
ISSN:1552-5260
1552-5279
DOI:10.1016/j.jalz.2018.06.069